Analysis of Using Low Dose 3 Factor PCC (Bebulin®) for INR Reversal in Patients with Warfarin Induced Severe/Life-Threatening Bleeding

Autor: Mekan, Sabeen F. *, Logdberg, Lennart, Stein, Arline *, Nash, Leah *, Cohen, Jessica *, Rosenberg, David *
Zdroj: In Blood 6 December 2014 124(21):5043-5043
Databáze: ScienceDirect